Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Asset Writedowns and Impairment (2016 - 2025)

IGC Pharma (IGC) has disclosed Asset Writedowns and Impairment for 11 consecutive years, with $152000.0 as the latest value for Q1 2025.

  • Quarterly Asset Writedowns and Impairment rose 104.66% to $152000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was -$3.0 million through Mar 2025, up 4.84% year-over-year, with the annual reading at $152000.0 for FY2025, 63.44% up from the prior year.
  • Asset Writedowns and Impairment for Q1 2025 was $152000.0 at IGC Pharma, up from -$3.3 million in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $152000.0 in Q1 2025, with the low at -$3.3 million in Q1 2024.
  • Average Asset Writedowns and Impairment over 5 years is -$767000.0, with a median of $37000.0 recorded in 2021.
  • The sharpest move saw Asset Writedowns and Impairment soared 114.24% in 2023, then tumbled 2691.27% in 2024.
  • Over 5 years, Asset Writedowns and Impairment stood at $37000.0 in 2021, then tumbled by 2491.89% to -$885000.0 in 2022, then skyrocketed by 114.24% to $126000.0 in 2023, then crashed by 2691.27% to -$3.3 million in 2024, then skyrocketed by 104.66% to $152000.0 in 2025.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods came in at $152000.0, -$3.3 million, and $126000.0 for Q1 2025, Q1 2024, and Q1 2023 respectively.